Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01807169
Other study ID # 12-AOI-05
Secondary ID 2012-005365-12
Status Completed
Phase Phase 4
First received
Last updated
Start date May 14, 2013
Est. completion date November 7, 2017

Study information

Verified date August 2018
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The endoscopic management of patients on anti platelet agents (APA) is a wide problem, with prevalence of patients on this type of therapy steadily increasing. The benefit / risk balance to stop or continue the APA for the digestive endoscopic procedure confronts us every day in clinical practice to another: the relationship thrombosis / hemorrhage.

Molecules most commonly used today are aspirin and clopidogrel. Current recommendations from the European Society of Gastrointestinal Endoscopy (ESGE) allow the maintenance of aspirin for the polypectomy. Some preliminary data show that the risk of bleeding during endoscopic mucosal resection (EMR) with aspirin is not significantly higher than polypectomy. The concept of polypectomy / EMR without stopping aspirin is progressively accepted and returned gradually to the usual practice. However, these procedures are still not allowed under clopidogrel, or in a dual APA therapy, in the absence of relevant data on the subject in the literature.

It is necessary to achieve a large national multicenter study, to clarify the risk of post recto colonic EMR and polypectomy bleeding in patients under clopidogrel alone or in combination (aspirin and clopidogrel) taking into account the endoscopic preventive measures used in daily practice by endoscopists in expert centers (clip, ligature and loop devices, preventive adrenalin injection).

The aim of the "MEDOC" study is to determine the incidence of immediate and delayed bleeding after colonic polypectomy and / or EMR for patients on clopidogrel.

It is expected in this work an incidence of post-polypectomy bleeding close to that observed during the implementation of these actions in the population without any anti platelet agents.


Description:

The endoscopic management of patients on anti platelet agents (APA) is a wide problem, due to the dramatically increasing prevalence of patients on these therapies. The benefit / risk balance to stop or continue the APA for the digestive endoscopic procedure confronts us every day in clinical practice to another: the relationship thrombosis / hemorrhage. The maintenance of an APA is particularly essential for acute coronary episode, but in the long term, in prevention of recurrent thrombotic cardiovascular disease. Molecules most commonly used today are aspirin and clopidogrel.

Current recommendations from the European Society of Gastrointestinal Endoscopy (ESGE) allow the maintenance of aspirin for the polypectomy. Some preliminary data show that the risk of bleeding during endoscopic mucosal resection (EMR) with aspirin is not significantly higher than polypectomy. The concept of polypectomy / EMR without stopping aspirin is progressively accepted and returned gradually to the usual practice. However, these procedures are still not allowed under clopidogrel, or in a dual APA therapy, in the absence of relevant data on the subject in the literature.

However recent studies disrupt this problem for different reasons: i) endoscopic haemostatic preventive measures have demonstrated efficacy in reducing the rate of immediate and delayed bleeding post polypectomy or EMR; ii) the inadequate modification or untimely stopping APA treatment is always complicated by severe vascular thrombosis events in 5% of patients; iii) three retrospective studies relativize the risk of bleeding after a colonic polypectomy under clopidogrel. It is therefore essential to carry out a prospective, large-scale, multicenter, study to clarify the risk of post colonic EMR/polypectomy bleeding in patients under clopidogrel alone or in combination (aspirin and clopidogrel) taking into account the endoscopic preventive measures used in daily practice by endoscopists in expert centers (clip, ligature and loop devices, preventive adrenalin injection).

The aim of the "MEDOC" study is to determine the incidence of immediate and delayed bleeding after colonic polypectomy and / or EMR for patients on clopidogrel.

The study presents an interventional prospective multicentric and national design.

300 patients will be included. The duration of the study inclusions will be 18 months.

It is expected in this work an incidence of post-polypectomy bleeding close to that observed during the implementation of these actions in the population without any anti platelet agents.


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date November 7, 2017
Est. primary completion date November 7, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age = 18 years, male or female

- Polypectomy AND / OR mucosectomy (EMR) performed on clopidogrel and/or aspirin during a colonoscopy with inability to defer action

- Taking a single daily dose of clopidogrel long-term (more than 3 months) or under treatment with clopidogrel and aspirin (aspirin < 375 mg more than 3 months) in the prevention of cardiovascular and thromboembolic risk with a major or medium - secondary prevention

- Affiliation to the regime of national health protection

- Informed consent and patient's written obtained

- No participation in another clinical study

Exclusion Criteria:

- Contraindications to the achievement of a lower gastrointestinal endoscopy

- Taking a single daily dose of clopidogrel or other anti-platelet, anti vitamin K (AVK), heparin or anti bi aggregation in the context of cardiovascular prevention

- Taking chronic anti inflammatory drug (at least once weekly)

- Resection technique submucosal dissection

- Haemorrhagic disease, disorders of hemostasis and coagulation (PT <60%, aPTT> 40 sec. And platelets <100000/mm3), hematologic malignancy, chronic liver cirrhosis classified as Child Pugh B or C, acute or chronic renal failure

- Acute Coronary Syndrome <3 months or not received percutaneous coronary intervention (PCI).

- Angioplasty with placement of a stent drug evaluation (out of context of acute coronary syndrome) <3 months.

- Angioplasty with placement of a bare metal stent (out of context of acute coronary syndrome) <4 weeks.

- Pregnant women, nursing

- Not signing the written consent and / or mental disabilities of the subject making its participation in the trial impossible

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Colonic polypectomy or endoscopic mucosal resection (EMR).
Resection of colonic polyps using polypectomy tehnique (with electrocoagulation) or mucosal resection (EMR or mucosectomy) with injection of physiological serum thus resection with electrocoagulation

Locations

Country Name City State
France Centre Hospitalier Universitaire de Bordeaux Bordeaux
France Centre Hospitalier Universitaire de Brest Brest
France Centre Hospitalier Universitaire de Nice Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of delayed bleeding after polypectomy and / or colonic mucosectomy Incidence of delayed bleeding after polypectomy and / or colonic mucosectomy (endoscopic mucosal resection) in patients on clopidogrel during surgery, hospitalization and at 30 days
Secondary Incidence of immediate bleeding after polypectomy and / or colonic mucosectomy during surgery, hospitalization and at 30 days
Secondary Incidence of severe bleeding after polypectomy and / or colonic mucosectomy in patients on Clopidogrel during surgery, hospitalization and at 30 days
Secondary Efficacy of endoscopic hemostasis in case of bleeding induced Defined by the cessation of bleeding without the need for further treatment (surgery, radiation) in case of bleeding induced
Secondary morbidity / mortality induced by immediate and delayed bleeding after polypectomy and / or colonic mucosectomy in patients on clopidogrel during surgery, hospitalization and at 30 days
Secondary predictors of gastrointestinal bleeding post polypectomy / mucosectomy under clopidogrel by sub groups of patients obtained during surgery, hospitalization and at 30 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Not yet recruiting NCT02754050 - Safety and Feasibility of the Tandem Snare Device N/A
Recruiting NCT02545699 - Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy N/A
Completed NCT02617992 - Systematic Wide-Field EMR Scar Assessment and Therapy Audit
Completed NCT01688557 - Trial on Innovative Technologies in Colonoscopy N/A
Completed NCT01481337 - Endoscopic Mucosal Colonic Resection and Polypectomy Under Aspirin N/A
Completed NCT02470416 - Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas N/A
Recruiting NCT00237276 - Experience and Enhancement: Improving Colonoscopic Polyp Detection N/A
Completed NCT00234650 - Adenoma Detection Rate With Position Change at Colonoscopy N/A
Recruiting NCT06096948 - Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection N/A
Recruiting NCT05042947 - A New Ligation Using the Double-loop Clips Technique Versus Traditional Techniques in the Treatment of Large Wounds After Endoscopic Resection N/A
Completed NCT02937506 - Patient Satisfaction With Propofol for Out Patient Colonoscopy Phase 4
Active, not recruiting NCT01369758 - MyoSure Hysteroscopic Tissue Removal System Registry Study Phase 4
Completed NCT00979342 - Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System N/A
Completed NCT00553436 - Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy N/A
Completed NCT00577083 - Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates N/A
Recruiting NCT03868605 - Endoscopic Full Thickness Resection Versus Standard Therapy of the Colorectal Neoplasia N/A
Completed NCT01917513 - Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy N/A
Active, not recruiting NCT03708952 - Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases
Completed NCT03146052 - Comparison Between Asymmetric And Standard Split-Dose Regimen For Bowel Preparation N/A